Wang Guiqiang, Duan Zhongping
Center for Liver Diseases, Department of Infectious Diseases, Peking University First Hospital; Department of Infectious and Liver Diseases, Peking University International Hospital, Beijing, China.
Center for Difficult and Complicated Liver Diseases and Artificial Liver, Beijing YouAn Hospital, Capital Medical University, Beijing, China.
J Clin Transl Hepatol. 2021 Oct 28;9(5):769-791. doi: 10.14218/JCTH.2021.00209. Epub 2021 Sep 28.
To achieve the goal of the World Health Organization to eliminate viral hepatitis as a major public health threat by 2030, the Chinese Society of Infectious Diseases and the Chinese Society of Hepatology convened an expert panel in 2019 to update the guidelines for the prevention and treatment of chronic hepatitis B (CHB). The current guidelines cover recent advances in basic, clinical, and preventive studies of CHB infection and consider the actual situation in China. These guidelines are intended to provide support for the prevention, diagnosis, and treatment of CHB.
为实现世界卫生组织到2030年消除病毒性肝炎这一重大公共卫生威胁的目标,中华医学会感染病学分会和中华医学会肝病学分会于2019年召集了一个专家小组,以更新慢性乙型肝炎(CHB)的预防和治疗指南。当前指南涵盖了CHB感染的基础、临床和预防研究的最新进展,并考虑了中国的实际情况。这些指南旨在为CHB的预防、诊断和治疗提供支持。